Sanarus Medical develops and markets minimally invasive devices for the diagnosis and treatment of breast tumors.
Sanarus Medical, Inc. develops and markets minimally invasive devices for the diagnosis and treatment of breast tumors. It offers Visica treatment system for cryoablation of breast fibroadenomas; Cassi II rotational core biopsy system, an automated hand held breast biopsy device to secure contiguous biopsy samples; and ImarC tissue marker system, a line of breast tissue markers that are visible under imaging modalities. The company was founded in 1999 and is headquartered in Pleasanton, California.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Feb 20, 2007 | Series E | $15M | 1 | — | — | Detail |
Apr 13, 2005 | Series D | $23M | 1 | — | — | Detail |
Nov 13, 2003 | Series C | $19.12M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Channel Medical Partners | — | Series E |